Novo Nordisk Adds to Manufacturing Capacity, Pumping Billions Into New Rare Disease Site

Novo Nordisk’s new Denmark site will produce drugs for rare diseases, such as hemophilias. Separately, the pharma giant said all regulatory conditions have been met for Novo Holdings’ acquisition of Catalent, which will bring to Novo Nordisk three manufacturing sites for GLP-1 medications. The post Novo Nordisk Adds to Manufacturing Capacity, Pumping Billions Into New…

Read More

3 effects of rising healthcare costs and how providers should respond

Healthcare affordability continues to decline as patients struggle with rising healthcare costs. Roughly half of U.S. adults report struggling to pay their medical bills. Patients are also frustrated with the lack of cost transparency, inaccurate estimates and confusion around what insurance covers and what’s owed out of pocket. When there’s a lack of understanding about…

Read More